CME Group to Scale Back Regulatory Reporting Business

The exchange group is closing several of its regulatory reporting businesses following a review finding they no longer align with its strategic direction.

cme

CME Group will wind down several of its regulatory reporting services on or by Nov. 30, 2020, following a review that found the services no longer align with the exchange operator’s business direction.

The decision follows the exchange’s acquisition of NEX Group in November 2018 and Acquis Exchange’s approval from the UK regulator to acquire NEX exchange in March 2020.

“Following an evaluation of our business portfolio … we have made the decision to wind down our Abide Financial and NEX

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

If you already have an account, please sign in here.

Interop tech buys time for buy-side fixed-income traders

A few buy-side traders and portfolio managers spearheading a drive for greater interoperability are reaping the rewards of increased workplace efficiency. Is interoperability the fixed-income panacea the buy side has been looking for?

GenAI and HFT: A competitive edge?

Timing is critical in the capital markets. IBM researchers say genAI’s predictive abilities in combination with AI/ML models can translate into profitable HFT opportunities.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here